Login
E-mail
Password
Mostra password
Ricorda
Password dimenticata?
Iscriviti gratuitamente
Registrazione
Registrazione
Parametri
Parametri
Quotazioni dinamiche 
OFFON

I Leader della Finanza

Ultime notizieSocietąMercatiEconomia & ForexMaterie PrimeTassiLeader della FinanzaPro. della FinanzaAgendaSettori 
HomeTutte le notizieLe notizie pił letteBiografie dei Leader della finanza
Portrait de Gil S. Omenn
Etą : 78
Patrimonio pubblico : 1 080 019 USD
Principali societą : Galectin Therapeutics Inc. - Angion Biomedica Corp. - Amesite Inc.
Riassunto 
Gil S. Omenn is Member-Community Preventive Services Task Force at Centers for Disease Control & Prevention, Affiliate Faculty at Institute for Systems Biology, Member of American Academy of Arts & Sciences, Member of Institute of Medicine, Member of Association of American Physicians and Vice President of Human Proteome Organization and on the board of 11 other companies.

In his past career Gil S. Omenn occupied the position of Chief Executive Officer of University of Miami Health System, Advisor at Arboretum Ventures, Inc., Chairman for tranSMART Foundation, Member-Scientific Management Review at National Institutes of Health, Associate Director at Office of Science & Technology Policy, Member of American College of Physicians, Inc., Chief Executive Officer of Michigan Medicine, Executive VP-Medical Affairs & Professor at the University of Michigan, Professor at the University of Washington and Council Member at National Academy of Medicine of United States.

Dr. Omenn received a doctorate from the University of Washington, a doctorate from Harvard Medical School and an undergraduate degree from Princeton University.


Posti e reponsabilitą di Gil S. Omenn 
NomeTitolo Da
Galectin Therapeutics Inc.
(Biotecnologia)
Independent Director 2014
Angion Biomedica Corp.
(Biotecnologia)
Independent Director 2020
Amesite Inc.
(Software)
Independent Director 2020
Armune BioScience, Inc. Director 2008
Phenomics Health, Inc. Director -
Life Sciences Society Director -
The Hastings Center Director -
The Center for Public Integrity Director -
The CNA Corp. Trustee -
Salzburg Global Seminar, Inc. Director -
Population Services International Director -
Human Proteome Organization Vice President 2011
Association of American Physicians Member -
Institute of Medicine Member -
American Academy of Arts & Sciences Member -
Institute for Systems Biology Affiliate Faculty 2009
Centers for Disease Control & Prevention Member-Community Preventive Services Task Force -


Participazioni di Gil S. Omenn 
NomeAzioni%Valorizzazione
Angion Biomedica Corp. (ANGN)
(Biotecnologia)
141 9830,48%592 069 USD
Galectin Therapeutics Inc. (GALT)
(Biotecnologia)
82 2400,14%260 701 USD
PRO PHARMACEUTICALS INC PFD SER A50 0003,57%158 500 USD
Amesite Inc. (AMST)
(Software)
41 6660,19%68 749 USD


Gil S. Omenn: network personale 
Le notizie pił lette 
24/11ELON MUSK: Musk vende azioni Tesla per 1,05 miliardi di dollari e compra 2,15 milioni di azioni
MR
06/12MUKESH AMBANI: I venditori indiani minacciano interruzioni di fornitura per protestare contro Reliance
MR
30/11JACK DORSEY: Jack Dorsey insegue cripto, fintech sogno post Twitter
MR
24/11JAMIE DIMON: Jamie Dimon scherza sul fatto che JPMorgan sopravviverà al partito comunista cinese
MR
01/12JACK DORSEY: Square, guidata da Dorsey, si ribattezza in Block in un cenno alla blockchain
MR
01/12Salesforce nomina Bret Taylor co-CEO, la previsione delle entrate delude
MR
24/11ERIK NORDSTROM: L'utile di Nordstrom manca le stime su problemi di supply-chain, le azioni crollano
MR
03/12TILMAN FERTITTA: FAST Acquisition rifiuta di terminare la fusione SPAC con Fertitta Entertainment
MR
29/11ANIL AMBANI: La banca centrale dell'India avvia la procedura di fallimento contro Reliance Capital; co per conformarsi
MR
29/11JACK DORSEY: Twitter, si dimette Ceo Jack Dorsey
RE
Pił notizie


© 2021 People and Ownership :   
Gil S. Omenn : connessioni